Baxter reports third-quarter 2026 results, raises outlook
Third-quarter sales increased 5%, while adjusted diluted EPS was $0.58. The company raised its full-year 2026 financial outlook and accelerated deleveraging by completing a $600 million debt tender offer.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed